Celldex Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -43.0% | +131.6% | -12.4% | +219.7% | -15.9% | -34.1% | -11.1% | +46.3% | -20.4% | +68.7% | -38.8% | +85.4% | +101.1% | -21.7% | -10.9% | +28.1% | +176.5% | -28.5% | +36.1% | +13.6% | -17.7% | -50.6% | -21.1% | +91.8% | +88.5% | -20.7% | +32.0% | +70.2% | -26.4% | |
| – | -44.4% | +110.8% | -7.1% | +257.5% | -16.3% | -40.3% | -13.7% | +54.8% | -28.8% | +72.3% | -61.3% | +186.8% | +78.4% | -25.0% | -13.1% | +55.6% | +258.6% | -32.8% | +43.9% | -33.7% | -26.0% | -31.6% | -32.7% | +196.6% | +107.7% | -22.7% | +35.9% | +73.1% | -28.4% | |
| – | -49.2% | +39.1% | +53.0% | +268.4% | -15.0% | -41.2% | -19.2% | +56.7% | -26.2% | +74.7% | -61.7% | +182.7% | +28.8% | -62.7% | -44.1% | +109.2% | +580.4% | -83.5% | +157.3% | -41.1% | -5.1% | -39.7% | -53.8% | +290.3% | -10.7% | -24.8% | +18.3% | -18.6% | +1.8% | |
| – | -49.2% | +39.1% | +53.0% | +268.4% | -15.0% | -41.2% | -19.2% | +56.7% | -26.2% | +74.7% | -88.0% | +801.5% | +86.3% | -25.9% | -12.7% | +57.5% | +260.9% | -33.6% | +44.2% | -34.5% | -26.5% | -32.6% | -31.7% | +202.9% | +110.0% | -25.3% | +38.3% | +72.0% | -28.5% | |
| – | – | – | – | -64.4% | +74.1% | -13.6% | +537.9% | +51.4% | -81.2% | -23.3% | -58.7% | +1,278.9% | -70.2% | -40.4% | -47.5% | -74.1% | +1,011.4% | -12.7% | +127.2% | +83.9% | +5.4% | +68.2% | -61.6% | +48.3% | -90.5% | +101.7% | +1,204.9% | -84.5% | +187.9% | |
| – | – | – | – | – | +20.8% | +99,900.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -5.7% | +543.9% | -17.5% | -15.3% | -5.7% | -16.1% | -20.8% | +38.4% | +5.6% | +8.8% | +15.1% | -21.4% | -41.1% | -34.0% | +80.2% | -10.2% | +18.8% | – | – | – | |
| – | – | – | – | – | – | – | – | -99.9% | 0.0% | +0.0% | +0.0% | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +914.8% | +0.0% | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -14.6% | -10.8% | -2.1% | -25.4% | -16.7% | -20.0% | -21.8% | -20.5% | +1,112.5% | -10.5% | -7.1% | -4.4% | -4.3% | -4.4% | -4.6% | +291.9% | -17.1% | -25.1% | -3.8% | -37.0% | -11.4% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +118.8% | +11.4% | -36.7% | +290.0% | -14.7% | -52.7% | -12.9% | +118.5% | +110.4% | +281.2% | -4.4% | -8.9% | +28.9% | -47.9% | -15.6% | +1.7% | -8.3% | +33.2% | +30.6% | +148.4% | -32.8% | -59.9% | -9.0% | -8.4% | -4.9% | +5.4% | +37.4% | +24.4% | +23.1% | |
| – | +75.0% | +17.9% | -33.3% | +145.3% | +2.3% | -37.8% | -1.4% | +61.0% | -32.3% | +173.1% | -2.5% | +43.4% | +2.2% | +40.3% | -29.2% | +23.7% | +15.1% | +20.3% | +23.5% | +16.5% | -21.3% | -54.6% | -7.6% | +22.0% | +16.3% | +12.6% | +67.2% | +26.9% | +29.1% | |
| – | – | +25.0% | -70.6% | -6.5% | – | – | – | – | +16.6% | +119.6% | +21.4% | -62.4% | +889.0% | +565.2% | -55.7% | -12.0% | – | – | +70.4% | +9.2% | +36.1% | -31.1% | -57.0% | -31.7% | +31.6% | -17.2% | +11.7% | -10.0% | +6.9% | |
| – | -33.3% | +100.0% | +43.8% | +56.8% | +25.2% | -26.0% | -43.1% | +268.3% | -34.9% | +123.8% | -70.6% | +581.6% | -71.7% | -35.6% | +0.4% | -20.3% | +201.1% | +16.0% | -42.1% | +15.5% | -1.4% | -37.7% | +9.8% | -10.7% | +17.2% | +172.0% | +4.6% | -6.6% | -63.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | -44.9% | +1,392.6% | -23.5% | -4.3% | -36.2% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -59.6% | +198.4% | -7.4% | +209.7% | -16.1% | -30.8% | -10.9% | +37.6% | -45.6% | -89.7% | -981.2% | – | +306.8% | +2.0% | -8.7% | +39.4% | +233.9% | -33.8% | +37.1% | -8.5% | -10.9% | -47.5% | -24.2% | +122.7% | +100.4% | -22.2% | +31.6% | +74.1% | -29.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +22.1% | +25.3% | +32.9% | +19.0% | +10.6% | +4.3% | +3.4% | +16.7% | +1.6% | +0.1% | +31.9% | +74.3% | +39.4% | +60.8% | +24.0% | +46.1% | +38.2% | +12.1% | +8.6% | +4.6% | +26.6% | +21.8% | +38.9% | +104.3% | +44.6% | +9.4% | +3.3% | +32.9% | +3.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.